Global Digital Therapeutics Market Report 2023: Rising Adoption of Digital Health Fuels the Sector - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Digital Therapeutics Market by Application, Type, End User - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The global digital therapeutics market is projected to reach $42.98 billion by 2030 at a CAGR of 31.1% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities.

The growth in the digital therapeutics market is mainly attributed to the rising adoption of digital health, increasing focus on preventive healthcare, growing prevalence of chronic diseases, and rising penetration of smart technologies, such as artificial intelligence, virtual reality, and the Internet of Things.

However, the data privacy concerns for digital therapeutic mobile applications restrain the growth of this market. The growing demand for digital therapeutic platforms in emerging economies and rising investment in digital therapeutics are expected to generate growth opportunities for the players operating in this market.

However, the lack of awareness about digital therapeutics platforms among the population and the lengthy process for regulatory approval are challenges for the players operating in this market.

Companies Mentioned

• Noom Inc. (U.S.)
• 2Morrow Inc. (U.S.)
• GAIA AG (Germany)
• ResMed Inc. (U.S.)
• Canary Health (U.S.)
• Welldoc Inc. (U.S.)
• DarioHealth Corp. (U.S.)
• Akili Inc. (U.S.)
• Biofourmis Inc. (U.S.)
• BigHealth (U.S.)
• Teladoc Health Inc. (U.S.)
• Limbix Health Inc. (U.S.)
• Kaia Health Software Inc. (Germany)
• Glooko Inc. (U.S.)
• Virta Health Corp. (U.S.)

Key Topics Covered:

1. Market Definition & Scope

2. Research Methodology

3. Executive Summary

4. Market Insights

4.1. Overview

4.2. Key Factors Affecting Market Growth

4.2.1. Impact Analysis of DROC

4.2.1.1. Increasing Focus on Preventive Healthcare and Self-testing is Driving the Market

4.2.1.2. Data Privacy Concerns Associated with Digital Therapeutics Applications are Restraining Market Growth

4.2.1.3. Emerging Economies and Growing Product Pipeline is Providing Opportunities for Market Growth

4.2.1.4. Lengthy and Tedious Regulatory Approval Process is Posing a Challenge to the Market's Growth

4.3. Trends

4.3.1. Partnership of Digital Therapeutics Companies with Pharmaceutical Companies

4.3.2. Integration of Artificial Intelligence (AI) in Digital Therapeutics

4.4. Regulatory and Reimbursement Approval Pathway

4.4.1. U.S.

4.4.2. Germany

4.4.3. France

4.4.4. Belgium

4.4.5. U.K.

4.4.6. China

4.4.7. Japan

4.4.8. South Korea

4.5. Case Study

4.5.1. Connected Inhalers to Reduce Asthma Symptoms (Propeller Health)

4.5.2. Sharp Rees-Stealy Medical Group (U.S.) Improves Outcomes with Diabetes Management Program

4.5.3. Improvement in Self-management of Diseases with Digital Health Solutions

5. Digital Therapeutics Market Assessment - by Type

5.1. Overview

5.2. Disease Management and Treatment DTx

5.3. Disease Prevention DTx

6. Digital Therapeutics Market Assessment - by Application

6.1. Overview

6.2. Mental Health

6.3. Diabetes

6.4. Cardiovascular Diseases

6.5. Gastrointestinal Disorders

6.6. Neurology

6.7. Rehabilitation & Patient Care

6.8. Respiratory Disorders

6.9. Oncology

6.10. Addiction Management

6.11. Sleep Disorders

6.12. Smoking Cessation

6.13. Other Applications

7. Digital Therapeutics Market Assessment - by End Users

7.1. Overview

7.2. Providers

7.3. Individual Consumers

7.4. Employers

7.5. Payers

7.6. Other End Users

8. Digital Therapeutics Market Assessment - by Geography

9. Competition Analysis

9.1. Introduction

9.2. Key Growth Strategies

9.3. Competitive Benchmarking

9.4. Competitive Dashboard

9.4.1. Industry Leaders

9.4.2. Market Differentiators

9.4.3. Vanguards

9.4.4. Emerging Companies

9.5. Company Ranking for Global Digital Therapeutics Market (2022)

10. Company Profiles

11. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/ylsgq6

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900